Moore Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$161M |
| 2 |
Amazon
AMZN
|
+$62.2M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$51.8M |
| 4 |
MGIC Investment
MTG
|
+$48.3M |
| 5 |
DexCom
DXCM
|
+$33M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$98.6M |
| 2 |
Moderna
MRNA
|
+$73.1M |
| 3 |
Canadian National Railway
CNI
|
+$72.9M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$69.7M |
| 5 |
Coupang
CPNG
|
+$60.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 25.56% |
| 2 | Technology | 10.69% |
| 3 | Consumer Discretionary | 9.59% |
| 4 | Industrials | 9.05% |
| 5 | Healthcare | 6.73% |
Similar funds
Moore Capital Management's Q4 2021 Portfolio in Review
As of Q4 2021, Moore Capital Management held 958 positions worth $5.04B, down 23% from $6.55B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Moore Capital Management withdrew a net $1.73B in Q4 2021, closing 231 positions and reducing 92 holdings. Its most notable exit was Moderna, an estimated $73.1M position sold in full.
By sector, the portfolio is most concentrated in Financials at 26% of assets, up from 17% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Moore Capital Management opened a new position in State Street SPDR S&P Biotech ETF worth $150M.
- Moore Capital Management's largest Q4 2021 buy was State Street SPDR S&P Biotech ETF: 1,335,600 shares worth $150M.
- Moore Capital Management added most to Amazon in Q4 2021, an estimated $62.2M increase.
- Moore Capital Management's biggest Q4 2021 reduction was Microsoft, cutting an estimated $98.6M.
- Moore Capital Management fully exited Moderna in Q4 2021, selling an estimated $73.1M.
- Moore Capital Management's ten largest holdings make up 28% of its $5.04B portfolio in Q4 2021.
- Moore Capital Management opened 171 new positions and closed 231 in Q4 2021.
- Moore Capital Management's portfolio value fell 23% quarter-over-quarter to $5.04B.
Based on Moore Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.